CIK 0001347178
- Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 030491827
- Phone
- +1 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- Open-market buys, last 90 days
- $38,094
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-02 | Kelly James Patrick EVP & Chief Financial Officer | Sale | −9,155 | $15.35 | $140K | 168,066 |
| 2018-01-02 | Kelly James Patrick EVP & Chief Financial Officer | Exercise or conversion · Restricted Stock Unit | −5,000 | 0 | ||
| 2018-01-02 | Kelly James Patrick EVP & Chief Financial Officer | Exercise or conversion · Restricted Stock Unit | −5,000 | 5,000 | ||
| 2018-01-02 | Kelly James Patrick EVP & Chief Financial Officer | Exercise or conversion · Restricted Stock Unit | −7,500 | 15,000 | ||
| 2018-01-02 | Gulino Richard L. SVP, General Counsel & Sec. | Exercise or conversion | +12,500 | 76,600 | ||
| 2018-01-02 | Gulino Richard L. SVP, General Counsel & Sec. | Exercise or conversion | +7,500 | 99,100 | ||
| 2018-01-02 | Gulino Richard L. SVP, General Counsel & Sec. | Sale | −10,367 | $15.20 | $158K | 88,733 |
| 2018-01-02 | Gulino Richard L. SVP, General Counsel & Sec. | Exercise or conversion · Restricted Stock Unit | −12,500 | 25,000 | ||
| 2018-01-02 | Gulino Richard L. SVP, General Counsel & Sec. | Exercise or conversion · Restricted Stock Unit | −7,500 | 15,000 | ||
| 2018-01-02 | Birznieks Gunther SVP, Business Development | Sale | −8,568 | $15.26 | $131K | 118,366 |
| 2017-12-28 | Polymeropoulos Mihael Hristos President and CEO | Gift | −10,000 | 1,031,848 | ||
| 2017-06-15 | Watkins Thomas Director | Grant or award | +5,000 | 5,000 | ||
| 2017-06-15 | Watkins Thomas Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2017-06-15 | MILANO VINCENT Director | Grant or award | +5,000 | 5,000 | ||
| 2017-06-15 | MILANO VINCENT Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2017-06-15 | DUGAN RICHARD W Director | Grant or award | +5,000 | 10,770 | ||
| 2017-06-15 | DUGAN RICHARD W Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2017-06-15 | COLA MICHAEL F Director | Grant or award | +5,000 | 5,000 | ||
| 2017-06-15 | COLA MICHAEL F Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2017-06-15 | BATE KENNETH Director | Grant or award | +5,000 | 5,000 |
Page 21 of 36 · 717 trades